Global CAS9 Technology Market Report
Global CAS9 Technology Market Report By Product Type (Consumables And Vectors), By Application (Genome Engineering, Disease Models And In Vitro Genetic Depletion), By Delivery Method (Physical Delivery Methods, Viral Delivery Methods And Non-Viral Delivery Methods), By End User (Biotechnology & Pharmaceutical Companies And Academic & Research Institutes) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2025-2033
ID:VMR11219908
April 2023
REPORT FORMATS: ELECTRONIC (PDF), MS EXCEL
The global demand for CAS9 Technology Market is presumed to reach the market size of nearly USD 6.12 BN by 2028 from USD 2.72 BN in 2021 with a CAGR of 12.3% under the study period 2022 - 2028.
CAS9 technology is a cutting-edge technique used in the field of genetics. It is based on the use of CRISPR-CAS9, a bacteria-based system that allows for the precise editing of DNA. By using CAS9 technology, scientists can target specific genes and make precise changes to the DNA sequence. This has numerous applications in the medical and research fields, such as the development of new treatments for genetic diseases and the study of how genes function in the body.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cas9 technology. The growth and trends of cas9 technology industry provide a holistic approach to this study.
By Product Type
By Application
By Delivery Method
By End User
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cas9 technology market include Cellecta Inc., abm Inc., GenScript, CRISPR Therapeutic, Intellia Therapeutics Inc., GE Healthcare, Takara Bio Inc., AstraZeneca PLC, Merck KGaA, Bio-Rad Laboratories Inc., Danaher Corporation (Integrated DNA Technologies Inc.), New England Biolabs, OriGene Technologies Inc., Lonza Group, Thermo Fisher Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
CAS9 technology is a cutting-edge technique used in the field of genetics. It is based on the use of CRISPR-CAS9, a bacteria-based system that allows for the precise editing of DNA. By using CAS9 technology, scientists can target specific genes and make precise changes to the DNA sequence. This has numerous applications in the medical and research fields, such as the development of new treatments for genetic diseases and the study of how genes function in the body.
Market Dynamics
CAS9 technology is gaining popularity because it provides a powerful and precise tool for editing DNA. The power to make precise changes to specific genes has many potential applications in the medical and research fields, such as the development of new treatments for genetic diseases and the study of how genes function in the body. As the advancement in technology continues, it has the potential to revolutionize the field of genetics and pave the way for new breakthroughs in medicine and science. Furthermore, the relatively low cost and ease of use of CAS9 technology make it attractive to researchers and labs. These factors are contributing to the growing popularity of CAS9 technology.The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cas9 technology. The growth and trends of cas9 technology industry provide a holistic approach to this study.
Market Segmentation
This section of the cas9 technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.By Product Type
- Consumables And Vectors
By Application
- Genome Engineering
- Disease Models And In Vitro Genetic Depletion
By Delivery Method
- Physical Delivery Methods
- Viral Delivery Methods And Non-Viral Delivery Methods
By End User
- Biotechnology & Pharmaceutical Companies And Academic & Research Institutes
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the CAS9 Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.Global CAS9 Technology Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cas9 technology market include Cellecta Inc., abm Inc., GenScript, CRISPR Therapeutic, Intellia Therapeutics Inc., GE Healthcare, Takara Bio Inc., AstraZeneca PLC, Merck KGaA, Bio-Rad Laboratories Inc., Danaher Corporation (Integrated DNA Technologies Inc.), New England Biolabs, OriGene Technologies Inc., Lonza Group, Thermo Fisher Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CAS9 TECHNOLOGY – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Delivery Method
3.7.4 Market Attractiveness Analysis By End User
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL CAS9 TECHNOLOGY MARKET ANALYSIS BY PRODUCT TYPE
6.1 Overview by Product Type
6.2 Historical and Forecast D...
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CAS9 TECHNOLOGY – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Delivery Method
3.7.4 Market Attractiveness Analysis By End User
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL CAS9 TECHNOLOGY MARKET ANALYSIS BY PRODUCT TYPE
6.1 Overview by Product Type
6.2 Historical and Forecast D...
Frequently Asked Questions (FAQs) about this Report
For the year 2021, the global market size for CAS9 technology was valued at USD 2.72 Billion.
The global CAS9 technology market growth is estimated to be close to 12.3% between 2023 and 2028.
In the global CAS9 technology market, North America holds the largest market share.
The global CAS9 technology market is segmented by Product Type (Consumables And Vectors), by Application (Genome Engineering, Disease Models And In Vitro Genetic Depletion), by Delivery Method (Physical Delivery Methods, Viral Delivery Methods And Non-Viral Delivery Methods), by End User (Biotechnology & Pharmaceutical Companies And Academic & Research Institutes).
The leading players in the global CAS9 technology market are Cellecta Inc., abm Inc., GenScript, CRISPR Therapeutic, Intellia Therapeutics Inc., GE Healthcare, Takara Bio Inc., AstraZeneca PLC, Merck KGaA, Bio-Rad Laboratories Inc., Danaher Corporation (Integrated DNA Technologies Inc.), New England Biolabs, OriGene Technologies Inc., Lonza Group, Thermo Fisher Scientific.
Choose Your Buying Option
Insights You Can Expect From This Report
